NCT06082817View on ClinicalTrials.gov

An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hypoactive Sexual Desire Disorder
Interventions
DRUG

Oral Testosterone Undecanoate

50mg oral testosterone undecanoate daily

Trial Locations (1)

92120

San Diego Sexual Medicine, San Diego

All Listed Sponsors
lead

San Diego Sexual Medicine

OTHER